Page 1,646«..1020..1,6451,6461,6471,648..1,6601,670..»

InVivo Therapeutics Opens First Site in the United Kingdom for … – Business Wire (press release)

Posted: Published on July 12th, 2017

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV)today announced that James Cook University Hospital in Middlesbrough, United Kingdom has been added as the UKs first clinical site for The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury. The Golden Jubilee Regional Spinal Cord Injuries Centre located at the James Cook University Hospital, a major trauma center, focuses exclusively on patients with spinal cord injuries and is one of eight specialist centers within England. I am enthusiastic about the opportunity to be joining the INSPIRE study and I look forward to helping InVivo evaluate this exciting experimental technology while bringing awareness of the study to the United Kingdom, Dr. Prasad said. Mark Perrin, InVivos CEO and Chairman, said, We are thrilled to open our first INSPIRE site in the United Kingdom and are looking forward to working with Dr. Prasad and the staff at James Cook University Hospital. The INSPIRE Study is now open for enrollment across three countries: the United States, Canada, and the United Kingdom. There are now 33 clinical sites participating in the clinical study: About The INSPIRE Study The INSPIRE … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on InVivo Therapeutics Opens First Site in the United Kingdom for … – Business Wire (press release)

Xadago Launched in US as Add-on Treatment for Parkinson’s Disease – Parkinson’s News Today

Posted: Published on July 12th, 2017

Xadago (safinamide) is now available in the U.S. as an add-on treatment for patients with Parkinsons disease currently taking levodopa/carbidopa to control their off episodes, according to an announcement from Newron PharmaceuticalsandUS WordMeds. Xadago is the first medication approved in more than 10 years by the U.S. Food and Drug Administration (FDA) to manage motor deficits in Parkinsons patients. Off periods are marked by an increase in disease symptoms, such as tremor and difficulties in walking, when a drugs effects are wearing off or arent working well. The approval of Xadagooffers an important new treatment option for the Parkinsons community, Stuart Isaacson, MD, director of the Boca Raton Institute for Neurodegenerative Disorders, said in a news release. Xadago is the first New Chemical Entity approved for the treatment of [Parkinsons disease]-related motor fluctuations in the U.S. in over a decade. In clinical trials, patients on once-daily Xadago demonstrated significant improvement in on time without troublesome dyskinesia. The approval of Xadago was supported by positive results obtained in clinical trials with more than 1,100 patients. These studies demonstrated that patients on levodopa treated with Xadago experienced significant increases in on time (when the drug works properly and symptoms are reduced) without … Continue reading

Posted in Parkinson's Treatment | Comments Off on Xadago Launched in US as Add-on Treatment for Parkinson’s Disease – Parkinson’s News Today

Less sitting and more moving: Parkinson’s support group starts in West Knoxville – WBIR-TV

Posted: Published on July 12th, 2017

Emily Stroud, WBIR 5:30 PM. EDT July 12, 2017 folded hands Medicine, therapy and exercise are ways to combat the symptoms of Parkinson's disease and so are emotional and social support. That's the purpose of a new West Knoxville Parkinson's support group. Exercise is part of it, including muscle stretches and reaches. It's movement to combat a movement disorder that gets progressively worse. "It's proven. The newest research really shows us to do a moving program every day. Minimum 30 minutes. It is really one of the best weapons. And it is not only for Parkinson's. It is for everybody," Isabell Senft-Daniel said. Senft-Daniel started a group in Maryville she calls PJ Parkinson's Support Group of Blount County. She got a lot of requests for another one in West Knoxville. Tuesday was the first get together at Wellpark at Shannondale on Middlebrook Pike. The group is for people with Parkinson's, their care partners and volunteers. "One of the big symptoms of Parkinson's is depression and anxiety and these are things nobody really talks about. We like to get folks out of the house to get together with other people and share their experience. It works very well in Maryville therefore … Continue reading

Posted in Parkinson's Treatment | Comments Off on Less sitting and more moving: Parkinson’s support group starts in West Knoxville – WBIR-TV

MU researchers find link between hormone-replacement therapy, breast cancer growth – Hannibal.net

Posted: Published on July 12th, 2017

Hormone replacement therapies, or medications containing female hormones that substitute those no longer produced by the body, often are prescribed to reduce the effects of menopausal symptoms in women. Research has indicated that women who take hormone replacement therapies have a higher incidence of breast cancer. Hormone replacement therapies, or medications containing female hormones that substitute those no longer produced by the body, often are prescribed to reduce the effects of menopausal symptoms in women. Research has indicated that women who take hormone replacement therapies have a higher incidence of breast cancer. Now, researchers at theUniversity of Missouri have linked natural and synthetic progestins to the bodys production of specialized cancer cells that act like stem cells in humans. Findings could help scientists target these rare cells that proliferate in breast cancers and metastasize elsewhere, and may help clinicians identify immunotherapies to combat the spread of the disease. In previous studies, we have shown that both natural and synthetic progestins accelerate the development of breast cancer and increase their metastasis to lymph nodes, said Salman Hyder, the Zalk Endowed Professor in Tumor Angiogenesis and professor of biomedical sciences in the College of Veterinary Medicine and the Dalton Cardiovascular Research Center. … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on MU researchers find link between hormone-replacement therapy, breast cancer growth – Hannibal.net

Supplements for Strength Athletes: What’s Changing, What’s New, and What’s Obsolete – BarBend (blog)

Posted: Published on July 12th, 2017

Editors note: This article is an op-ed. The views expressed herein and in the video are the authors and dont necessarily reflect the views of BarBend. Claims, assertions, opinions, and quotes have been sourced exclusively by the author. The desire to build stronger and faster athletes is never ending, and this has led to a never ending desire to unravel the science behind building better athletes. Appropriate exercise prescription and programming continues to undergo extensive research in the hopes of unlocking hidden clues to give athletes an edge. In addition, the science behind over the counter sports nutrition continues to move forward in the hopes of legally boosting athletic sports performance. But thanks to NDI guidelines (New Dietary Ingredients regulations) that have been drafted by the FDA, this side of the industry has hit a wall when it comes to ingredient innovation. It will now cost any raw material manufacturer a lot more money and time to validate a new material. In this industry a new ingredient typically means a synthetic duplicate of an existing ingredient found in minute amounts in nature, an extract of an active ingredient in an herb concentrated to larger amounts (ex: caffeine is naturally occurring … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Supplements for Strength Athletes: What’s Changing, What’s New, and What’s Obsolete – BarBend (blog)

First gene therapy ‘a true living drug’ on the cusp of FDA … – Washington Post

Posted: Published on July 12th, 2017

PHILADELPHIA When doctors saw the report on Bill Ludwigs bone-marrow biopsy, they thought it was a mistake and ordered the test repeated. But the results came back the same: His lethal leukemia had been wiped out by an experimental treatment never before used in humans. We were hoping for a little improvement, remembered the 72-year-old retired New Jersey corrections officer, who had battled the disease for a decade. He and his oncologist both broke down when she delivered the good news in 2010. Nobody was hoping for zero cancer. The pioneering therapy administered to Ludwig and a few other adults at the University of Pennsylvania hospital paved the way for clinical trials with children. Six-year-old Emily Whitehead, who was near death, became the first pediatric recipient in 2012. Like Ludwig, she remains cancer-free. Such results are why the treatment is on track to become the first gene therapy approved by the Food and Drug Administration. An FDA advisory committee will decide Wednesday whether to recommend approval of the approach, which uses patients own genetically altered immune cells to fight blood cancers. If the panel gives the nod, the agency probably will follow suit by the end of September. That would … Continue reading

Posted in Cell Therapy | Comments Off on First gene therapy ‘a true living drug’ on the cusp of FDA … – Washington Post

Cell therapy may be key to treating Alzheimer’s & Parkinson’s – Economic Times

Posted: Published on July 12th, 2017

According to recent study, advancements in materials from this study could potentially help patients requiring stem cell therapies for spinal cord injuries, stroke, Parkinsons disease, Alzheimers disease, arthritic joints or any other condition requiring tissue regeneration. Earlier research revolved around the role of autoimmunity in terms of a treatment. Its important in the context of cell therapies for people to cure these diseases or regenerate tissues that are no longer functional, shared Samuel I. Stupp, director of Northwesterns Simpson Querrey Institute for BioNanotechnology and Board of Trustees Professor of Materials Science and Engineering, Chemistry, Medicine and Biomedical Engineering. Cells in our bodies are constantly being signalled with many types of instructions coming from proteins and other molecules present in the matrices that surround them. For example, these can be cues for cells to express specific genes so they can proliferate or differentiate into several types of cells leading to growth or regeneration of tissues. One of the marvels of this signalling machinery is the built-in capacity in living organisms to make signals stop and restart as needed, or to switch off one signal and activate a different one to orchestrate very complex processes. Building artificial materials with this type of … Continue reading

Posted in Cell Therapy | Comments Off on Cell therapy may be key to treating Alzheimer’s & Parkinson’s – Economic Times

Clinical trial for stem-cell therapy to reverse liver cirrhosis – The Straits Times

Posted: Published on July 12th, 2017

SINGAPORE - The use of stem cells to reverse liver cirrhosis - or the hardening of the liver - is being explored in a clinical trial. Conducted by a multi-centre team led by the National University Hospital (NUH), doctors aim to determine if stem cell therapy can improve liver function. Previously, liver cirrhosis, caused by various diseases such as chronic hepatitis B and non-alcoholic fatty liver disease, was thought to be irreversible. A liver transplant provides a definitive cure to end-stage cirrhosis. However, in Singapore, less than 5 per cent of end-stage liver cirrhosis patients receive a liver transplant. The number of people on the waiting list for a liver transplant has been increasing over the years, according to statistics from the Ministry of Health. In 2007, there were nine on the waiting list, compared with 57 last year. There are around 50 waiting for a liver transplant this year. Also, many patients do not fulfil the eligibility criteria to receive a liver transplant due to other health complications or being above the age limit of 70 years. The $2.6 million study, which was launched on Tuesday (July 11),is funded by the National Medical Research Counciland 46 patients will be … Continue reading

Posted in Cell Therapy | Comments Off on Clinical trial for stem-cell therapy to reverse liver cirrhosis – The Straits Times

American Medical Association Adding Cytori’s Cell-Based Therapy for Scleroderma Hand Problems to Key Database – Scleroderma News

Posted: Published on July 12th, 2017

TheAmerican Medical Associationis adding descriptions ofCytori Therapeuticscell-based therapy for scleroderma of the hands to its authoritative database of medical procedures, services and technology. Because so many players in the American healthcare system use the database as a reference, the addition of thedescriptions will help Cytori spread the word in the medical community about the HabeoCell Therapyit is developing. The company said the descriptions will also help it continue to advance the therapy through the clinical trial process. A code accompanies each of the descriptions in the AMAsCurrent Procedural Terminology database. The code-based descriptions provide information about medical procedures and services to doctors, patients, government healthcare agencies, medical accreditation associations, health insurance companies and others. The AMAsCurrent Procedural Terminology Editorial Panel approved Cytoris request to add the descriptions to the databases Category III listings, which cover emerging healthcare technology, procedures and services. The AMA has published the two codes and the descriptions that they cover on its website. They will become effective on Jan. 1, 2018. Cytori worked with the American College of Rheumatology, the American Society of Plastic Surgeons, and the American Society for Surgery of the Handon its application request to the AMA. We applaud the Editorial Panels approval … Continue reading

Posted in Cell Therapy | Comments Off on American Medical Association Adding Cytori’s Cell-Based Therapy for Scleroderma Hand Problems to Key Database – Scleroderma News

A tall order: Giraffe receives stem-cell therapy for chronic arthritis – Source

Posted: Published on July 12th, 2017

How do veterinarians help a giraffe ease its arthritis pain? Well, it takes a little more than an aspirin and a gulp of water. Recently, Colorado State University veterinarians traveled to Cheyenne Mountain Zoo to help Mahali, a 14-year-old giraffe, with arthritis pain in his front left hoof. Arthritis is a common problem for giraffes, especially geriatric giraffes like Mahali. Who can blame them? Weighing in at 2,000 pounds on average, their four feet support more than one ton of weight. Thats like carrying two grand pianos on your back all day. With its 17-giraffe herd trained for voluntary husbandry, including hoof trims, blood draws and radiographs, Cheyenne Mountain Zoo is uniquely suited to help find better arthritis treatments for giraffes. Dr. Amanda Morphet, who is training to specialize in exotic and zoo animal medicine at CSU, believes stem-cell therapy can help alleviate arthritis pain. Currently, arthritis in these megavertebrates is managed through corrective hoof trims, non-steroidal anti-inflammatories, cold-laser therapy and pain medications. But, these practices are not always enough to keep giraffes, which can live up to 30 years, comfortable as they age. CSU veterinarians Dr. Val Johnson and Dr. Amanda Morphet, and the zoos lead veterinarian Dr. Liza … Continue reading

Posted in Cell Therapy | Comments Off on A tall order: Giraffe receives stem-cell therapy for chronic arthritis – Source

Page 1,646«..1020..1,6451,6461,6471,648..1,6601,670..»